Literature DB >> 11021953

A novel process for updating recommendations for managing hypertension: rationale and methods.

K B Zarnke1, N R Campbell, F A McAlister, M Levine.   

Abstract

BACKGROUND: There are numerous hypertension consensus recommendations intended for practising physicians. However, recommendations in their current format have limited impact on improving hypertension control.
MATERIALS AND METHODS: A group of national societies, headed by the Canadian Hypertension Society, the Heart and Stroke Foundation of Canada, the Canadian Coalition for High Blood Pressure Prevention and Control, and Health Canada has developed strategies to maintain annually updated recommendations for hypertension management and to provide greater opportunities for their implementation into clinical practice. The process is overseen by a steering committee. Subcommittees have been formed for each of a list of topics seen as important to the control of hypertension. The subcommittees, with the aid of a central librarian, conduct annual literature reviews in accordance with Cochrane Collaboration strategies. Modified existing and new recommendations are forwarded to a group with expertise in clinical epidemiology. Grades of evidence are assigned to each recommendation. Revised recommendations based on the above process will be presented annually at the conjoint Canadian Hypertension Society/Canadian Cardiovascular Congress meeting. Under the leadership of the Cardiovascular Disease Division of the Laboratory Centre for Disease Control, Health Canada, a committee has been charged with the implementation process.
CONCLUSIONS: The improvements of the current process over previous national hypertension recommendations are four-fold. First, the recommendations will be updated annually. Second, the methodology has been improved. Third, the grading system can be used in the evaluation of complex study designs. Finally, the implementation process is extended. The authors are optimistic that these changes will contribute to the improvement of hypertension control in the Canadian population.

Entities:  

Mesh:

Year:  2000        PMID: 11021953

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  27 in total

1.  2000 Canadian hypertension recommendations. Summary of recommendations affecting family physicians.

Authors: 
Journal:  Can Fam Physician       Date:  2001-04       Impact factor: 3.275

2.  2001 Canadian hypertension recommendations. What has changed?

Authors: 
Journal:  Can Fam Physician       Date:  2002-10       Impact factor: 3.275

3.  The 2001 Canadian hypertension recommendations: take-home messages.

Authors:  Norman R C Campbell; Denis Drouin; Ross D Feldman
Journal:  CMAJ       Date:  2002-09-17       Impact factor: 8.262

4.  2003 Canadian hypertension recommendations. It's not all old hat.

Authors:  Robert J Petrella
Journal:  Can Fam Physician       Date:  2004-04       Impact factor: 3.275

5.  Canadian efforts to prevent and control hypertension.

Authors:  Norman R C Campbell; Guanmin Chen
Journal:  Can J Cardiol       Date:  2010 Aug-Sep       Impact factor: 5.223

6.  The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.

Authors:  B R Hemmelgarn; Finlay A McAlister; Steven Grover; Martin G Myers; Donald W McKay; Peter Bolli; Carl Abbott; Ernesto L Schiffrin; George Honos; Ellen Burgess; Karen Mann; Thomas Wilson; Brian Penner; Guy Tremblay; Alain Milot; Arun Chockalingam; Rhian M Touyz; Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

7.  The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.

Authors:  N A Khan; Finlay A McAlister; Simon W Rabkin; Raj Padwal; Ross D Feldman; Norman Rc Campbell; Lawrence A Leiter; Richard Z Lewanczuk; Ernesto L Schiffrin; Michael D Hill; Malcolm Arnold; Gordon Moe; Tavis S Campbell; Carol Herbert; Alain Milot; James A Stone; Ellen Burgess; B Hemmelgarn; Charlotte Jones; Pierre Larochelle; Richard I Ogilvie; Robyn Houlden; Robert J Herman; Pavel Hamet; George Fodor; George Carruthers; Bruce Culleton; Jacques Dechamplain; George Pylypchuk; Alexander G Logan; Norm Gledhill; Robert Petrella; Sheldon Tobe; Rhian M Touyz
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

Review 8.  Guidelines for the management of chronic kidney disease.

Authors:  Adeera Levin; Brenda Hemmelgarn; Bruce Culleton; Sheldon Tobe; Philip McFarlane; Marcel Ruzicka; Kevin Burns; Braden Manns; Colin White; Francoise Madore; Louise Moist; Scott Klarenbach; Brendan Barrett; Robert Foley; Kailash Jindal; Peter Senior; Neesh Pannu; Sabin Shurraw; Ayub Akbari; Adam Cohn; Martina Reslerova; Vinay Deved; David Mendelssohn; Gihad Nesrallah; Joanne Kappel; Marcello Tonelli
Journal:  CMAJ       Date:  2008-11-18       Impact factor: 8.262

Review 9.  The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future.

Authors:  F A McAlister; N R Campbell; K Zarnke; M Levine; I D Graham
Journal:  CMAJ       Date:  2001-02-20       Impact factor: 8.262

10.  Hypertension treatment and control rates: chart review in an academic family medicine clinic.

Authors:  Sara J Houlihan; Scot H Simpson; Andrew J Cave; Nigel W Flook; Mary E Hurlburt; Chris J Lord; Linda L Smith; Harvey H Sternberg
Journal:  Can Fam Physician       Date:  2009-07       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.